ask="4.64"
ask_size="2200"
average_daily_volume="192856"
bid="3.60"
bid_size="10000"
book_value="1.98"
change="-0.23"
change_from_200_day_moving_average="-0.23"
change_from_50_day_moving_average="0.10"
change_from_52_week_high="-4.11"
change_From_52_week_low="0.82"
change_in_percent="-5.39%"
close="4.04"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.39"
ebitda="-35.85M"
eps_estimate_current_year="-2.28"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.14"
ex_dividend_date="N/A"
float_shares="8580000"
high="4.30"
high_52_weeks="8.15"
last_trade_date="1/27/2017"
last_trade_price="4.04"
last_trade_size="235"
last_trade_time="3:59pm"
low="3.80"
low_52_weeks="3.22"
market_capitalization="75.35M"
moving_average_200_day="4.27"
moving_average_50_day="3.94"
name="Catabasis Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="17.00"
open="4.30"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-5.34%"
percent_change_from_50_day_moving_average="+2.52%"
percent_change_from_52_week_high="-50.43%"
percent_change_from_52_week_low="+25.47%"
previous_close="4.27"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.16"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18652000"
short_ratio="1.60"
stock_exchange="NGM"
symbol="CATB"
volume="279845"
weeks_range_52="3.22 - 8.15"
